The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InAs institutional investors pivot toward defensive stocks with accelerating operational performance, Paradiem LLC acquired 154,940 shares in Colgate-Palmolive valued at $13.21 million during the first quarter of 2026. This strategic move follows the company's report of robust financial results, featuring earnings of $0.97 per share and total revenue of $5.32 billion, marking a significant 8.4% year-over-year increase.
This investment underscores confidence in Colgate-Palmolive's ability to outperform within the consumer staples sector, particularly when compared to peers like Procter & Gamble, which reported 3% organic sales growth in its latest filings per market data. Paradiem LLC's initiation of this new position, now their 14th largest holding, highlights the positive sentiment surrounding the company's recent earnings and revenue beat.
Regarding stock performance, CL stood at $92.24 (at close July 10, 2026), trading within a daily range of $91.32 to $92.72. Traders are closely monitoring broader economic indicators affecting consumer health; recent ISM Services PMI data showed a steady reading of 54, suggesting continued expansion in non-manufacturing sectors which remains a critical backdrop for consumer goods demand.